We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Aerie Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 156 → 0 (-156)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $703M → $0 (-$703M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
–
Holders Change
-156
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
153
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
DM
Deerfield Management
New York
-$73.5M
2
BlackRock
BlackRock
New York
-$53.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$36.9M
4
UBS Group
UBS Group
Switzerland
-$36.4M
5
WIC
Water Island Capital
New York
-$31.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
– -$73.5M -4,855,005 Closed
BlackRock
2
BlackRock
New York
– -$53.6M -3,544,947 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$36.9M -2,441,120 Closed
UBS Group
4
UBS Group
Switzerland
– -$36.4M -2,405,832 Closed
WIC
5
Water Island Capital
New York
– -$31.5M -2,082,516 Closed
NAM
6
Nexpoint Asset Management
Texas
– -$28.7M -1,893,891 Closed
RHJA
7
Rice Hall James & Associates
California
– -$24.3M -1,603,458 Closed
Schroder Investment Management Group
8
Schroder Investment Management Group
United Kingdom
– -$22.7M -1,500,183 Closed
Morgan Stanley
9
Morgan Stanley
New York
– -$20M -1,319,893 Closed
LCS
10
Levin Capital Strategies
New York
– -$17M -1,125,395 Closed
Citigroup
11
Citigroup
New York
– -$16.7M -1,100,775 Closed
Bank of America
12
Bank of America
North Carolina
– -$16.4M -1,081,133 Closed
AA
13
AQR Arbitrage
Connecticut
– -$16.3M -1,078,446 Closed
AAM
14
Alpine Associates Management
Florida
– -$15.6M -1,028,900 Closed
PA
15
Pinnacle Associates
New York
– -$14.6M -964,759 Closed
State Street
16
State Street
Massachusetts
– -$14.4M -951,675 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$14.2M -939,811 Closed
Geode Capital Management
18
Geode Capital Management
Massachusetts
– -$13.1M -862,809 Closed
Renaissance Technologies
19
Renaissance Technologies
New York
– -$12M -795,473 Closed
Deutsche Bank
20
Deutsche Bank
Germany
– -$11.2M -740,882 Closed
FAM
21
Fred Alger Management
New York
– -$9.05M -598,325 Closed
JP Morgan Chase
22
JP Morgan Chase
New York
– -$8.5M -562,108 Closed
NYLIM
23
New York Life Investment Management
New York
– -$7.86M -519,661 Closed
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
– -$7.11K -468,900 Closed
MAM
25
Miria Asset Management
Malta
– -$7.02M -463,900 Closed
1
2 3 4 5

AERI Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2022, worth a combined $0 — down 100% from $703M a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of AERI and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $73.5M sold.

  • 0 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2022, down from 156 in Q3 2022.
  • Funds reported $0 of Aerie Pharmaceuticals stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Aerie Pharmaceuticals positions in Q4 2022 and 153 closed out, a net change of -153 holders.
  • The largest Aerie Pharmaceuticals seller in Q4 2022 was Deerfield Management, an estimated $73.5M sold.

Based on aggregated 13F filings for Q4 2022.